Alerts will be sent to your verified email
Verify Email
GANGAPHARM
|
Ganga Pharma.
|
Hind Bio Science
|
Kobo Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.71 % | -24.99 % | -1.77 % |
|
5yr average Equity Multiplier
|
1.37 | 3.76 | 4.06 |
|
5yr Average Asset Turnover Ratio
|
0.31 | 0.25 | 0.54 |
|
5yr Avg Net Profit Margin
|
1.72 % | -39.56 % | -3.79 % |
|
Price to Book
|
0.98 | 6.98 | 0.0 |
|
P/E
|
87.37 | 283.12 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
237.0 Days | 197.57 Days | 0.0 |
|
Inventory Days
|
165.67 Days | 0.0 | 89.28 Days |
|
Days Receivable
|
126.89 Days | 198.39 Days | 0.0 |
|
Days Payable
|
119.78 Days | 104.32 Days | 147.48 Days |
|
5yr Average Interest Coverage Ratio
|
1.32 | -32.49 | 0.99 |
|
5yr Avg ROCE
|
3.77 % | -14.28 % | 11.79 % |
|
5yr Avg Operating Profit Margin
|
0.19 % | -38.68 % | 8.83 % |
|
5 yr average Debt to Equity
|
0.28 | 2.68 | 1.62 |
|
5yr CAGR Net Profit
|
31.95 % | n/a | n/a |
|
5yr Average Return on Assets
|
0.53 % | -8.2 % | -0.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.91 % | 12.19 % | 44.95 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-15.8 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ganga Pharma.
|
Hind Bio Science
|
Kobo Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|